Lolamicin, a novel antibiotic developed from a pyridinepyrazole precursor, exhibits potent activity against a broad range of Gram-negative multidrug-resistant clinical isolates, and good efficacy in mouse models of infection without inducing gut dysbiosis.
- Kristen A. Muñoz
- Rebecca J. Ulrich
- Paul J. Hergenrother